Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Circ Heart Fail. 2016 Feb;9(2):e002206. doi: 10.1161/CIRCHEARTFAILURE.115.002206

Table 4.

ROS and 4-HNE levels and MITO complexes I, II, III, IV, and V abundances in LV myocardium of normal dogs (n=6), untreated heart failure control dogs (HF-CON) (n=7) and elamipretide-treated heart failure dogs (HF+ELA) (n=7).

Normal HF-CON HF+ELA
LV Tissue ROS (RLUx104/μg protein) 0.77±0.04 1.45±0.18* 0.90±0.06*
4-HNE adducts (ng/mg protein) 185±21 399±35* 252±18*
Complex-I subunit (du) 0.51±0.02 0.15±0.01* 0.29±0.03*
Complex-II subunit (du) 0.45±0.06 0.14±0.01* 0.34±0.02*
Complex-III subunit (du) 0.40±0.07 0.16±0.02* 0.27±0.03*
Complex-IV subunit (du) 0.61±0.04 0.26±0.05* 0.44±0.03*
Complex-V subunit (du) 4.97±0.32 2.12±0.37* 2.81±0.50*

ROS=reactive oxygen species; 4-HNE=4-hydroxynonenal. All data are Mean±SEM.

*

p<0.05 vs. Normal;

p<0.05 vs. HF-CON.